Relating to prior authorization for prescription drug benefits related to the treatment of neurodegenerative diseases.
1
What it does
Plain-language analysis is being updated.
Use the official record and source text while enrichment finishes.
2
Where do you stand?
Choose your position
3
Tell your reps
Take a position to see your representatives and ways to contact them.
4
More on this bill
Where it stands
Introduced
Passed Senate
3Passed House
4To Governor
5Became Law
Looking ahead
No hearings or votes scheduled.
History
2025
May 8Referred to InsuranceLatest
May 8Read first timeMinor
May 7Received from the SenateMinor
Vote recorded Senate Rule 7.18 and the Constitutional Rule requiring bills to be read on three several days be suspended and that CSSB 1525 be placed on its third reading and final passage. Result: pass.Upper
May 7Reported engrossed
May 7Record vote
May 7PassedPassed Senate
May 7Read 3rd timeMinor
May 7Record vote
May 7Three day rule suspended
May 7Vote recorded in Journal
May 7Read 2nd time & passed to engrossmentMinor
May 7Vote recorded in Journal
May 7Rules suspended-Regular order of business
May 7Co-author authorized
May 6Placed on intent calendar
May 5Committee report printed and distributed
May 5Recommended for local & uncontested calendar
May 5Reported favorably as substitutedMinor
Apr 30Vote taken in committee
Apr 30Considered in public hearing
Apr 23Left pending in committee
Apr 23Testimony taken in committee
Apr 23Considered in public hearing
Apr 23Scheduled for public hearing on . . .
Mar 6Referred to Health & Human ServicesMinor
Mar 6Read first timeMinor
Feb 21FiledMinor
Feb 21Received by the Secretary of the SenateIntroduced